Nurse Practitioner, Family · Las Vegas, NV
NPI
1497383020
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
888 W Bonneville Ave
Las Vegas, NV, 89106
Phone (702) 483-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
1,989 services
Medicare patients, 2024
148
Average age 61
Drug cost, 2024
$4.2M
1,795 prescriptions
Company payments, 2025
$13K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin Wilkinson was code 99215 (office e&m - established), 190 times for 116 patients. In total Erin Wilkinson billed 1,989 services in 19 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 190 | 116 | $102.76 | $20K |
| 97530 PT Treatment | Office | 58 | 11 | $16.45 | $954 |
| 36415 Venipuncture Blood Collection | Office | 37 | 28 | $8.65 | $320 |
| 99443 Telephone Services | Office | 27 | 21 | $68.59 | $1,852 |
| 99214 Office E&M - Established | Office | 17 | 16 | $79.51 | $1,352 |
By year: 2022 $29K for 287 services; 2023 $35K for 1,697 services; 2024 $34K for 1,989 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 37 | 28 | $8.65 | $320 |
Medicare prescription drug claims, 2024
In 2024, the drug Erin Wilkinson prescribed most often to Medicare patients was Baclofen, with 236 prescriptions and refills. In total Erin Wilkinson wrote 1,795 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 236 | 490 | 70 | $4,690 |
| Gabapentin Generic | 187 | 403 | 55 | $5,160 |
| Dalfampridine Er Dalfampridine | 119 | 175 | 24 | $42K |
| Modafinil Generic | 98 | 121 | 22 | $3,333 |
| Clonazepam Generic | 88 | 93 | 15 | $402 |
| Tizanidine Hcl Generic | 83 | 171 | 18 | $1,302 |
| Teriflunomide Generic | 79 | 79 | Under 11 | $23K |
| Kesimpta Pen Ofatumumab | 57 | 57 | Under 11 | $526K |
| Bupropion Xl Bupropion Hcl | 44 | 106 | 13 | $1,464 |
| Duloxetine Hcl Generic | 43 | 123 | 13 | $1,148 |
| Trazodone Hcl Generic | 28 | 59 | Under 11 | $163 |
| Fingolimod Fingolimod Hcl | 27 | 27 | Under 11 | $102K |
| Copaxone Glatiramer Acetate | 27 | 31 | Under 11 | $194K |
| Dimethyl Fumarate Generic | 24 | 36 | Under 11 | $45K |
| Pregabalin Generic | 24 | 30 | Under 11 | $354 |
Brand drugs: 290 claims; generic drugs: 1,505 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin Wilkinson $13K ($13K in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.